Volume 8, Number 9, September 2002

Research

Characterization of Flagella Produced by Clinical Strains of Stenotrophomonas maltophilia

Doroti de Oliveira-Garcia,*† Monique Dall'Agnol,‡ Mónica Rosales,‡ Ana C.G.S. Azzuz,§ Marina B. Martinez,†§ and Jorge A. Girón‡
*Laboratório Clínico do Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil; †Departamento de Microbiologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil; ‡Benemerita Universidad Autónoma de Puebla, Puebla, México; and §Departamento de Análises Clínicas da Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, São Paulo, Brazil

Figure 5. Identification of the 38-kDa flagellin protein SM_FliC in clinical isolates of Stenotrophomonas maltophilia. Lane 1, SMDP14; lane 2, SMDP275; lane 3, SMHC176; lane 4, SMHC181; lane 5, SMDP315; lane 6, SMDP314; and lane 7, SMHC179. Lane 8, the purified SM_FliC, was used as positive control. The immunoblot shows the presence of the 38-kDa flagellin protein in all the isolates. Doublet bands were seen in some of the isolates. Molecular weight standards and the 38-kDa flagellin protein are indicated by arrows.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed July 26, 2002

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention